It is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Drugs for miotics and glaucoma
Timolol Maleate is a beta-adrenoceptor blocking agent; Timolol has the action of reducing elevated intraocular pressure, whether or not accompanied by glaucoma. The action of Timolol is usually rapid, occurring approximately 20 minutes following ocular instillation and maximum effect occurs in one to two hours. Significant lowering of intraocular pressure has been maintained for periods as long as 24 hours with Timolol 0.25% or 0.50%. Unlike miotics, Timolol has practically no effect on pupil size. No change in visual acuity has observed.
One drop in the affected eye(s) once a day in the AM
Beta-blocking agents may lead to hypotension and/or severe bradycardia, and when combined with Timolol Maleate may produce additive effects. Ophthalmic supervision is required in case of concomitant therapy with eye drops containing adrenaline (mydriasis may occur).
Bronchial asthma,a history of bronchial asthma,severe chronic obstructive pulmonary disease. ? Sinus bradycardia,second or third degree atrioventricular block,overt cardiac failure,cardiogenic shock. ? Hypersensitivity to any component of this product
Blurred vision,cataract,conjunctival injection,headache,hypertension,infection,itching and decreased visual acuity.
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Timolol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation: Timolol has been detected in breast milk following oral and ophthalmic drug administration. Because of the potential for serious adverse reactions from Timolol in nursing infants,a decision should be made whether to discontinue nursing or to discontinue the drug,taking into account the importance of the drug to the mother.
dizziness, headache, shortness of breath, bradycardia, bronchospasm, and
cardiac arrest
The drug is to be used within 30 days after first opening. Store at 15°-25°C. Protect from light. The bottle is to be closed strongly immediately after use. keep out of reach of children.
.png&w=384&q=75)